About the Study : In this Special Communication from the National Cancer Institute (NCI), authors examine consistent support for the study of obesity and cancer research. Authors reviewed grant data from fiscal years 2015 to 2022. While the data supports investment in a strong evidence base, authors flag multiple opportunities for advancing science. This includes funding for less studied areas, such as obesity’s impact on cancer treatment and survivorship, obesity and cancer throughout the lifespan, obesity and cancer disparities, and the study of obesity as it relates to multiple cancer sites. Additionally, as use of GLP-1 medications continues to expand, new opportunities may emerge to examine how intentional, pharmacologically induced weight loss may influence cancer risk, treatment response, and survivorship.
Corresponding Author : Tanya Agurs-Collins, PhD, RD, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD ( collinsta@mail.nih.gov ).
10.1001/jamanetworkopen.2026.28773
To access the embargoed study: Visit our JAMA Network Media Center at this link https://media.jamanetwork.com/
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Editor's Note : Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
JAMA Network Open